Literature DB >> 7983769

Inhibition of dengue virus by novel, modified antisense oligonucleotides.

K Raviprakash1, K Liu, M Matteucci, R Wagner, R Riffenburgh, M Carl.   

Abstract

Five different target regions along the length of the dengue virus type 2 genome were compared for inhibition of the virus following intracellular injection of the cognate antisense oligonucleotides and their analogs. Unmodified phosphodiester oligonucleotides as well as the corresponding phosphorothioate oligonucleotides were ineffective in bringing about a significant inhibition of the virus. Novel modified phosphorothioate oligonucleotides in which the C-5 atoms of uridines and cytidines were replaced by propynyl groups caused a significant inhibition of the virus. Antisense oligonucleotide directed against the target region near the translation initiation site of dengue virus RNA was the most effective, followed by antisense oligonucleotide directed against a target in the 3' untranslated region of the virus RNA. It is suggested that the inhibitory effect of these novel modified oligonucleotides is due to their increased affinity for the target sequences and that they probably function via an RNase H cleavage of the oligonucleotide:RNA heteroduplex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983769      PMCID: PMC188549          DOI: 10.1128/JVI.69.1.69-74.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.

Authors:  M Simons; E R Edelman; J L DeKeyser; R Langer; R D Rosenberg
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

Review 2.  Applications of antisense oligodeoxynucleotides in virology.

Authors:  A D Malcolm; J Coulson; N Blake; L C Archard
Journal:  Biochem Soc Trans       Date:  1992-11       Impact factor: 5.407

Review 3.  Oligodeoxynucleotides as antisense inhibitors of gene expression.

Authors:  M K Ghosh; J S Cohen
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1992

4.  Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90).

Authors:  J Fu; B H Tan; E H Yap; Y C Chan; Y H Tan
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

5.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

6.  Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.

Authors:  R W Wagner; M D Matteucci; J G Lewis; A J Gutierrez; C Moulds; B C Froehler
Journal:  Science       Date:  1993-06-04       Impact factor: 47.728

7.  Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.

Authors:  K A Higgins; J R Perez; T A Coleman; K Dorshkind; W A McComas; U M Sarmiento; C A Rosen; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 8.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

Authors:  W B Offensperger; S Offensperger; E Walter; K Teubner; G Igloi; H E Blum; W Gerok
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  14 in total

Review 1.  Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes.

Authors:  C D Blair; Z N Adelman; K E Olson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.

Authors:  Tia S Deas; Iwona Binduga-Gajewska; Mark Tilgner; Ping Ren; David A Stein; Hong M Moulton; Patrick L Iversen; Elizabeth B Kauffman; Laura D Kramer; Pei-Yong Shi
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications.

Authors:  Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

4.  Pathogen-derived resistance to dengue type 2 virus in mosquito cells by expression of the premembrane coding region of the viral genome.

Authors:  P J Gaines; K E Olson; S Higgs; A M Powers; B J Beaty; C D Blair
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Authors:  Richard M Kinney; Claire Y-H Huang; Becky C Rose; Andrew D Kroeker; Theo W Dreher; Patrick L Iversen; David A Stein
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.

Authors:  N M Cirino; G Li; W Xiao; P F Torrence; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells.

Authors:  Q Xie; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 8.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

9.  Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome.

Authors:  Pruksa Nawtaisong; James Keith; Tresa Fraser; Velmurugan Balaraman; Andrey Kolokoltsov; Robert A Davey; Stephen Higgs; Ahmed Mohammed; Yupha Rongsriyam; Narumon Komalamisra; Malcolm J Fraser
Journal:  Virol J       Date:  2009-06-04       Impact factor: 4.099

10.  Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

Authors:  H Zhang; R Hanecak; V Brown-Driver; R Azad; B Conklin; M C Fox; K P Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.